Dental implants in patients with oral lichen planus: A narrative review

Pons-Fuster, Alvaro; Jornet, Pia López
July 2014
Quintessence International;Jul2014, Vol. 45 Issue 7, p599
Academic Journal
Objective: To evaluate the success and survival rates of dental implants in patients with oral lichen planus (OLP). Method and Materials: A narrative review literature search was conducted in the PubMed/Medline, Scopus, and Cochrane databases for articles published between 1990 and April 2013, using key search words “dental implants” and “oral lichen planus”. Results: This review did not identify any publications that were randomized controlled trials. A total of 60 OLP patients and 199 dental implants were analyzed. Three cases of OLP-related oral squamous cell carcinoma were reported. Conclusion: The extent and severity of underlying disease should be determined before dental implant placement.


Related Articles

  • Oral Lichenoid Lesions ‑ A Review and Update. Kamath, Venkatesh Vishwanath; Setlur, Krishnanand; Yerlagudda, Komali // Indian Journal of Dermatology;Jan/Feb2015, Vol. 60 Issue 1, p1 

    Background: Oral lichenoid lesions or reactions (OLLs/OLRs) are clinical and histological contemporaries of the classical oral lichen planus (OLP) that have generated a lot of debate in literature. In contrast to the idiopathic nature of OLP, OLLs are often associated with a known identifiable...

  • The Influence of Restorative Procedures on Esthetic Outcomes in Implant Dentistry: A Systematic Review. Martin, William C.; Pollini, Adrien; Morton, Dean // International Journal of Oral & Maxillofacial Implants;2014 Supplement, Vol. 29, p142 

    Purpose: The objectives of this review were to (1) identify if prosthodontic parameters influence the esthetic outcome of implant-supported restorations and (2) make clinically relevant recommendations based upon the findings. Materials and Methods: Electronic and manual searches of dental...

  • Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy. Lieberman, Daniel Z.; Massey, Suena H. // Core Evidence;2009, Vol. 4 Issue 1, p67 

    Introduction: Desvenlafaxine, the active metabolite of venlafaxine, is a serotonin norepinephrine reuptake inhibitor (SNRI) recently approved for the treatment of major depressive disorder. It is one of only three medications in this class available in the United States. Aims: The objective of...

  • Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout. Gaffo, Angelo L.; Saag, Kenneth G. // Core Evidence;2009, Vol. 4 Issue 1, p25 

    Introduction: Gout is a common and disabling cause of arthritis in middle-aged and elderly populations, with its main predisposing factor being hyperuricemia (serum urate > 6.8 mg/dL). Options for treatment of chronic gout until 2008 were allopurinol, a xanthine oxidase inhibitor, and the group...

  • Raltegravir: The evidence of its therapeutic value in HIV-1 infection. Ramkumar, Kavya; Neamati, Nouri // Core Evidence;2009, Vol. 4 Issue 1, p131 

    Introduction: The antiretroviral treatment paradigm for human immunodeficiency virus-1 (HIV-1) infection has undergone a significant change with the addition of a new class of therapeutic agents targeting HIV-1 integrase (IN). IN inhibitors prevent the integration of viral DNA into the human...

  • Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation. Deibert, Peter; Xander, Carola; Blum, Hubert E.; Becker, Gerhild // Core Evidence;2009, Vol. 4 Issue 1, p247 

    Introduction: Constipation is a distressing side effect of opioid treatment, being so irksome in some cases that patients would rather suffer the pain than the side effect of opioid analgesics. Stool softeners or stimulating laxatives are often ineffective or even aggravate the situation. A new...

  • Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis. Krulig, Eliana; Gordon, Kenneth B. // Core Evidence;2010, Vol. 5 Issue 1, p11 

    Introduction: Psoriasis is a chronic inflammatory skin disease affecting approximately 2% to 3% of the population worldwide. Discoveries over the past 3 to 5 years have significantly altered our view of psoriasis as primarily a T-cell mediated condition. The most recent research has demonstrated...

  • Luliconazole for the treatment of fungal infections: an evidence-based review. Khanna, Deepshikha; Bharti, Subhash // Core Evidence;2014, Vol. 9, p113 

    Abstract: Luliconazole is an imidazole antifungal agent with a unique structure, as the imidazole moiety is incorporated into the ketene dithioacetate structure. Luliconazole is the R-enantiomer, and has more potent antifungal activity than lanoconazole, which is a racemic mixture. In this...

  • Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation. McCarty, E. J.; Dinsmore, W. W. // Core Evidence;2012, Vol. 7, p1 

    Premature ejaculation (PE) is a major issue in male sexual health. The global prevalence of PE is estimated to be between 20% and 40%, making it the most common sexual dysfunction in men. PE causes distress and reduced quality of life for patients and has a negative impact on interpersonal...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics